Cosciens Biopharma Inc (CSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 05-1995 | 02-1995 | 11-1994 | 05-1994 | 02-1994 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 4,995 | 5,093 | 0 | 3,286 | 3,152 |
| TOTAL | $4,995 | $5,093 | $N/A | $3,286 | $3,152 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 1,733 | 1,770 |
| Other Non-Current Assets | 5,542 | 5,605 | 5,668 | 6,594 | 6,724 |
| TOTAL | $5,542 | $5,605 | $5,668 | $8,327 | $8,494 |
| Total Assets | $10,537 | $10,698 | $5,668 | $11,613 | $11,646 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 2,352 | 2,732 |
| Accounts payable and accrued liabilities | 3,425 | 3,114 | 2,716 | 636 | 1,097 |
| Accrued Expenses | N/A | N/A | N/A | 1,294 | 618 |
| Other current liabilities | N/A | N/A | N/A | 162 | 202 |
| TOTAL | $3,425 | $3,114 | $2,716 | $4,444 | $4,649 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,425 | $3,114 | $2,716 | $4,444 | $4,649 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | 54 | 53 |
| Other shareholders' equity | 0 | 0 | 0 | 90 | 77 |
| TOTAL | $N/A | $N/A | $N/A | $10,061 | $9,599 |
| Total Liabilities And Equity | $3,425 | $3,114 | $2,716 | $14,505 | $14,248 |